Skip to content

Rx Laverdia-CA1 (Verdinexor Tablets) Dog Cancer Treatment for Lymphoma

SKU 012VED-7004
$176.80
Availability:
Out of stock
Availability:
Out of stock
Availability:
Out of stock
Availability:
Out of stock
Size: 2.5mg
Count: 50 Tablets
Prescription Icon

Free Shipping over $49

Rx items qualify for free shipping over $49 (excludes vaccines).

Prescription Icon

Prescription Item

Requires Veterinarian Authorization when shipped to all states. We'll collect your pet's prescription information at Checkout.

Rx Laverdia-CA1 (Verdinexor Tablets) for Dogs

Laverdia-CA1 (verdinexor tablets) is a veterinary-prescribed cancer treatment conditionally approved by the FDA for the management of lymphoma in dogs. This innovative oral therapy works at the cellular level to help slow the progression of cancer by blocking the export of tumor suppressor proteins from the cell nucleus—leading to the disruption and eventual death of cancer cells.

As the first FDA conditionally approved oral tablet for canine lymphoma, Laverdia-CA1 provides a convenient at-home treatment option, allowing pet owners to support their dog’s care plan with guidance from their veterinarian.

Features:

  • Conditionally FDA-approved for the treatment of lymphoma in dogs
  • Contains verdinexor, a targeted therapy that disrupts cancer cell function
  • Helps slow cancer progression by retaining tumor suppressor proteins in the cell nucleus
  • Convenient oral tablet for at-home administration
  • First oral tablet of its kind approved for canine lymphoma treatment

Directions:

Use only as directed by your veterinarian. Follow all dosing instructions carefully and attend regular veterinary check-ups to monitor your dog’s response to treatment.

Ingredients:

Verdinexor

Cautions and Warnings:

Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian. For use in dogs only. Not for human use. Keep out of reach of children.

Pregnant women, women who may become pregnant, nursing women, and children should not handle this medication or come into contact with treated dogs’ bodily fluids (urine, feces, saliva, or vomit) for at least 3 days after administration. Always wear protective disposable chemotherapy-resistant gloves when handling tablets or contaminated materials.

Do not use in dogs that are pregnant, lactating, or intended for breeding. This medication may affect fertility and is considered a potential teratogen. Dogs should be closely monitored for changes in bloodwork and overall health during treatment.

Common side effects may include decreased appetite, weight loss, vomiting, diarrhea, lethargy, increased thirst or urination, and changes in liver enzymes or platelet counts. Contact your veterinarian if serious or persistent side effects occur.

 

This product requires a Valid prescription.

All prescription items are Non-Refundable and Non-Returnable.

California Prop 65 WARNING

Cancer and Reproductive Harm - www.p65warnings.ca.gov